Compare WLFC & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLFC | MLAB |
|---|---|---|
| Founded | 1985 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 801.2M | 719.9M |
| IPO Year | 1997 | 1995 |
| Metric | WLFC | MLAB |
|---|---|---|
| Price | $38.54 | $130.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $70.50 | ★ $117.50 |
| AVG Volume (30 Days) | ★ 235.8K | 71.1K |
| Earning Date | 11-06-2026 | 11-09-2026 |
| Dividend Yield | ★ 1.37% | 0.50% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | ★ 2.39 | 0.49 |
| Revenue | ★ $569,223,000.00 | N/A |
| Revenue This Year | $2.18 | $2.14 |
| Revenue Next Year | $6.05 | $6.45 |
| P/E Ratio | ★ $16.32 | $262.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.67 | $69.51 |
| 52 Week High | $81.54 | $144.35 |
| Indicator | WLFC | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 59.82 | 52.78 |
| Support Level | $36.39 | $120.65 |
| Resistance Level | $51.95 | $132.70 |
| Average True Range (ATR) | 1.97 | 4.16 |
| MACD | -0.63 | -0.26 |
| Stochastic Oscillator | 36.19 | 54.59 |
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum Lease rent revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.